TGA changes continue to impact and sometimes baffle pharmacists

A number of recent decisions by the Therapeutic Goods Administration (TGA) are highly relevant to pharmacists in Australia. Firstly, the interim decision from the...

TGA outcomes of listed sunscreen products review

Pharmacists may recall news headlines earlier this year about people experiencing significant sunburn despite application of high sun protection factor sunscreens. Reports were accompanied...

How to get the most out of your PSA21 Virtual experience

There are just two days until PSA21 Virtual begins, with an exciting program of clinical, therapeutic and industry sessions for pharmacists in all practice settings.

Health leaders unite behind pharmacists in general practice

At the GP pharmacist symposium, leading health bodies have called for investment in general practice pharmacists to make medicine use safer. 

The pain of uncertainty: Managing pain without codeine

With over-the-counter (OTC) codeine products being upscheduled, pharmacists and pharmacy staff need to review and understand every patient’s pain. In doing so, there’s an...

Complementary medicines: Rheumatoid arthritis

Rheumatoid arthritis (RA) is a chronic autoimmune disease characterised by joint inflammation. The immune system attacks the tissue lining the joints (synovial membrane), causing...